Article Details

Asher Bio adds $55M and takes a page from nature for cancer immunotherapy

Retrieved on: 2021-03-23 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Asher Bio adds $55M and takes a page from nature for cancer immunotherapy. View article details on hiswai:

Excerpt

Third Rock Ventures led Asher's Series A round of financing. Other investors included Boxer Capital of Tavistock Group, Invus, Y Combinator, and ...

Article found on: medcitynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up